Strong student-teacher relationships are among the most powerful predictors of academic success. Yet many educators struggle to build and sustain them, especially in classrooms affected by stress and ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

This is not a drill—the 2025 MarketingProfs B2B Forum program is here! You won't want to miss the lineup of incredible speakers and insightful, inspirational sessions they're bringing to B2B Forum ...

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study showed ...

Take a look at all our Aerospace, Defense and Space, Air Transport, MRO and Business Aviation webinars. Led by our expert editors and top-level contributors from their fields, our webinars offer ...

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England ...